Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | D-1553 |
Synonyms | |
Therapy Description |
D-1553 is a KRAS G12C inhibitor that may inhibit growth of tumors harboring KRAS G12C (Cancer Res 2021;81(13_Suppl):Abstract nr 932). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
D-1553 | D1553|D 1553 | KRAS G12C inhibitor 28 | D-1553 is a KRAS G12C inhibitor that may inhibit growth of tumors harboring KRAS G12C (Cancer Res 2021;81(13_Suppl):Abstract nr 932). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04585035 | Phase Ib/II | D-1553 | Study to Evaluate D-1553 in Subjects With Solid Tumors | Recruiting | USA | 3 |